Current:Home > FinanceMax Scherzer has back surgery, will miss much of 2024 season for Rangers -WealthDrive Solutions
Max Scherzer has back surgery, will miss much of 2024 season for Rangers
View
Date:2025-04-13 04:15:27
When Max Scherzer exited his World Series Game 3 start with a back injury, it was far more serious than it appeared.
Scherzer underwent recent back surgery to repair a herniated disk, Rangers general manager Chris Young told reporters Friday, an injury that will sideline him for most of the 2024 season's first half.
And with Scherzer, a three-time Cy Young Award winner and future Hall of Famer, set to celebrate his 40th birthday in July, it's a significant setback for a pitcher with nearly 3,000 innings pitched on his odometer.
Scherzer will earn $43.3 million in 2024, the final year of a three-year deal he signed with the New York Mets before the 2022 season. Yet when the Mets slipped from contention last season, he agreed to a trade to Texas, where he backfilled a rotation slot left by Jacob deGrom's elbow injury.
The Mets agreed to pay $30.8 million of Scherzer's 2024 salary, with the Rangers responsible for the remaining $12.5 million.
HOT STOVE UPDATES: MLB free agency: Ranking and tracking the top players available.
He posted a 3.20 ERA in eight starts with Texas, but suffered a teres major shoulder strain that ended his season in September. Scherzer rehabbed the injury as the Rangers began their playoff run and made a pair of so-so starts in the American League Championship Series against Houston.
Scherzer had pitched three scoreless innings in World Series Game 3 when he motioned to the dugout that he could not continue.
Young told reporters Thursday that Scherzer attempted "conservative treatments in pain management" before opting for surgery, considered a last resort for managing disk herniation.
Wednesday, the Rangers agreed to a two-year contract with starter Tyler Mahle, who won't be available at the start of the season as he recovers from Tommy John surgery. They also expect deGrom to return and join World Series hero Nathan Eovaldi and Jon Gray in the rotation, along with holdovers Andrew Heaney and Dane Dunning.
veryGood! (56164)
Related
- The FBI should have done more to collect intelligence before the Capitol riot, watchdog finds
- iCarly Cast Recalls Emily Ratajkowski's Hilarious Cameo
- #BookTok: Here's Your First Look at the Red, White & Royal Blue Movie
- N.C. Church Takes a Defiant Stand—With Solar Panels
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- Climate Tipping Points Are Closer Than We Think, Scientists Warn
- State of the Union: Trump Glorifies Coal, Shuts Eyes to Climate Risks
- Singer Ava Max slapped on stage, days after Bebe Rexha was hit with a phone while performing
- Federal appeals court upholds $14.25 million fine against Exxon for pollution in Texas
- ‘Super-Pollutant’ Emitted by 11 Chinese Chemical Plants Could Equal a Climate Catastrophe
Ranking
- 'We're reborn!' Gazans express joy at returning home to north
- Legendary Singer Tina Turner Dead at 83
- Vanderpump Rules' Tom Sandoval Claims His and Ariana Madix's Relationship Was a Front
- Beyoncé Honors Tina Turner's Strength and Resilience After Her Death
- The city of Chicago is ordered to pay nearly $80M for a police chase that killed a 10
- N.C. Church Takes a Defiant Stand—With Solar Panels
- Duke Energy Takes Aim at the Solar Panels Atop N.C. Church
- A new nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval
Recommendation
Average rate on 30
People with disabilities aren't often seen in stock photos. The CPSC is changing that
FDA advisers narrowly back first gene therapy for muscular dystrophy
Greenland’s Nearing a Climate Tipping Point. How Long Warming Lasts Will Decide Its Fate, Study Says
The FBI should have done more to collect intelligence before the Capitol riot, watchdog finds
Elliot Page Grateful to Be Here and Alive After Transition Journey
FDA advisers narrowly back first gene therapy for muscular dystrophy
Cops say they're being poisoned by fentanyl. Experts say the risk is 'extremely low'